Literature DB >> 12707027

Estrogen deficiency accelerates progression of glomerulosclerosis in susceptible mice.

Sharon J Elliot1, Michael Karl, Mariana Berho, Mylene Potier, Feng Zheng, Baudouin Leclercq, Gary E Striker, Liliane J Striker.   

Abstract

Estrogen deficiency may contribute to the development and progression of glomerulosclerosis in postmenopausal women. The responsiveness to estrogens could be controlled by genetic traits related to those that determine the susceptibility to glomerular scarring. This study was undertaken to determine whether the intensity of the sclerotic response was modified by the estrogen status in sclerosis-prone ROP Os/+ mice. Ovariectomized ROP Os/+ mice developed more severe renal dysfunction and glomerulosclerosis than intact, ie, estrogen sufficient age-matched female mice. Ovariectomized ROP Os/+ exhibited increased accumulation of extracellular matrix, predominantly of laminin, and a marked distortion of the glomerular architecture. We found an increase in macrophage infiltration in the mesangium of ovariectomized ROP Os/+. Estrogen deficiency decreased glomerular estrogen receptor expression in ROP Os/+ mice, which we had previously found to be low in the parental ROP strain. Thus, although physiological estrogen levels in young ROP Os/+ mice could not prevent the development of glomerulosclerosis, estrogen deficiency accelerated the progression of glomerular scarring in this mouse strain. This suggests that estrogen replacement will slow but not prevent the progression of glomerulosclerosis. It underscores the importance of the genetic composition of individuals that determines the susceptibility to diseases as well as the response to treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12707027      PMCID: PMC1851210          DOI: 10.1016/S0002-9440(10)64277-0

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  22 in total

1.  Selective activation of the N-glycosylation apparatus in uteri by estrogen.

Authors:  D D Carson; J D Farrar; J Laidlaw; D A Wright
Journal:  J Biol Chem       Date:  1990-02-15       Impact factor: 5.157

2.  Estrogen-related abnormalities in glomerulosclerosis-prone mice: reduced mesangial cell estrogen receptor expression and prosclerotic response to estrogens.

Authors:  Mylène Potier; Michael Karl; Feng Zheng; Sharon J Elliot; Gary E Striker; Liliane J Striker
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

3.  Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta.

Authors:  Yan Zhu; Zhao Bian; Ping Lu; Richard H Karas; Lin Bao; Daniel Cox; Jeffrey Hodgin; Philip W Shaul; Peter Thoren; Oliver Smithies; Jan-Ake Gustafsson; Michael E Mendelsohn
Journal:  Science       Date:  2002-01-18       Impact factor: 47.728

4.  Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.

Authors:  D M Herrington; D M Reboussin; K B Brosnihan; P C Sharp; S A Shumaker; T E Snyder; C D Furberg; G J Kowalchuk; T D Stuckey; W J Rogers; D H Givens; D Waters
Journal:  N Engl J Med       Date:  2000-08-24       Impact factor: 91.245

5.  The limits of the cellular capacity to mediate an estrogen response.

Authors:  P Webb; G N Lopez; G L Greene; J D Baxter; P J Kushner
Journal:  Mol Endocrinol       Date:  1992-02

6.  Familial clustering of end-stage renal disease in Mississippi.

Authors:  Donald E Butkus
Journal:  J Miss State Med Assoc       Date:  2002-03

7.  Estradiol suppresses mesangial cell type I collagen synthesis via activation of the MAP kinase cascade.

Authors:  J Neugarten; I Medve; J Lei; S R Silbiger
Journal:  Am J Physiol       Date:  1999-12

8.  Estradiol down-regulates MCP-1 expression in human coronary artery endothelial cells.

Authors:  Emre Seli; Tugce Pehlivan; Belgin Selam; Juan A Garcia-Velasco; Aydin Arici
Journal:  Fertil Steril       Date:  2002-03       Impact factor: 7.329

9.  Glomerulosclerosis at both early and late stages is associated with increased cell turnover in mice transgenic for growth hormone.

Authors:  C M Pesce; L J Striker; E Peten; S J Elliot; G E Striker
Journal:  Lab Invest       Date:  1991-11       Impact factor: 5.662

10.  Age-related changes in alpha 1- and alpha 2-chain type IV collagen mRNAs in adult mouse glomeruli: competitive PCR.

Authors:  E P Peten; A Garcia-Perez; Y Terada; D Woodrow; B M Martin; G E Striker; L J Striker
Journal:  Am J Physiol       Date:  1992-11
View more
  37 in total

Review 1.  Sexual dimorphism in the aging kidney: differences in the nitric oxide system.

Authors:  Chris Baylis
Journal:  Nat Rev Nephrol       Date:  2009-06-02       Impact factor: 28.314

2.  Estrogen receptor beta protects against in vivo injury in RPE cells.

Authors:  Sharon J Elliot; Paola Catanuto; Diego G Espinosa-Heidmann; Pedro Fernandez; Eleut Hernandez; Peter Saloupis; Kenneth Korach; Michael Karl; Scott W Cousins
Journal:  Exp Eye Res       Date:  2009-09-30       Impact factor: 3.467

3.  Differential effects of continuous and intermittent 17beta-estradiol replacement and tamoxifen therapy on the prevention of glomerulosclerosis: modulation of the mesangial cell phenotype in vivo.

Authors:  Michael Karl; Mariana Berho; Judith Pignac-Kobinger; Gary E Striker; Sharon J Elliot
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

Review 4.  Sexual dimorphism: the aging kidney, involvement of nitric oxide deficiency, and angiotensin II overactivity.

Authors:  Chris Baylis
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-09-07       Impact factor: 6.053

5.  Estrogen receptor subtype ratio change protects against podocyte damage.

Authors:  Paola Catanuto; Xiaomei Xia; Simone Pereira-Simon; Sharon Elliot
Journal:  Curr Trends Endocinol       Date:  2017

6.  Antifibrotic effect of tamoxifen in a model of progressive renal disease.

Authors:  Humberto Dellê; José Roberto C Rocha; Rita C Cavaglieri; José Mauro Vieira; Denise M A C Malheiros; Irene L Noronha
Journal:  J Am Soc Nephrol       Date:  2011-11-03       Impact factor: 10.121

7.  Oxidant stress and mitochondrial signaling regulate reversible changes of ERα expression and apoptosis in aging mouse glomeruli and mesangial cells.

Authors:  Simone Pereira-Simon; Xiaomei Xia; Paola Catanuto; Sharon Elliot
Journal:  Endocrinology       Date:  2012-10-01       Impact factor: 4.736

8.  Sexual dimorphism, the aging kidney, and involvement of nitric oxide deficiency.

Authors:  Chris Baylis
Journal:  Semin Nephrol       Date:  2009-11       Impact factor: 5.299

9.  Identifying advanced glycation end products as a major source of oxidants in aging: implications for the management and/or prevention of reduced renal function in elderly persons.

Authors:  Helen Vlassara; Jaime Uribarri; Luigi Ferrucci; Weijing Cai; Massimo Torreggiani; James B Post; Feng Zheng; Gary E Striker
Journal:  Semin Nephrol       Date:  2009-11       Impact factor: 5.299

10.  Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjogren's syndrome.

Authors:  Gil-Jin Shim; Margaret Warner; Hyun-Jin Kim; Sandra Andersson; Lining Liu; Jenny Ekman; Otabek Imamov; Margaret E Jones; Evan R Simpson; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.